Literature DB >> 19127718

Molecular orbital basis for yellow curry spice curcumin's prevention of Alzheimer's disease.

Krishnan Balasubramanian1.   

Abstract

It is demonstrated by using high-level ab initio computations that the yellow curcumin pigment, bis-(4-hydroxy-3-methoxyphenyl)-1,6-diene-3,5-dione, in the east Indian root plant turmeric (Curcuma longa) exhibits unique charge and bonding characteristics that facilitate penetration into the blood-brain barrier and binding to amyloid beta (Abeta). Alzheimer's disease is caused by Abeta accumulation in the brain cells combined with oxidative stress and inflammation. Consistent with the recent experimental work by Cole and co-workers (Yang, F., et al. J. Biol. Chem. 2004, 280, 5892-5901) that demonstrates curcumin pigment's binding ability to Abeta both in vivo and in vitro, it is shown here that curcumin possesses suitable charge and bonding features to facilitate the binding to Abeta. In addition, curcumin's anti-inflammatory and antioxidant properties are also attributed to electronic and structural features. It is shown that the presence of an enolic center and two phenolic polar groups separated by an essentially hydrophobic bridge of a conjugated network provides both hydrophobic and hydrophilic features to the curcumin pigment, thereby facilitating penetration into the blood-brain barrier through the former property and then binding to Abeta oligomer through the latter property. Both density functional and Møller-Plesset perturbation (MP2) computations have been carried out on the curcumin pigment to obtain fully optimized geometries in the gas phase and aqueous solution and also the atomic charges. Different isomers (keto and enol forms) have been considered to show that the enol form is the most favored and has all of the properties for an ideal antioxidant with also features to penetrate the blood-brain barrier and to bind to Abeta. This is demonstrated with natural bond charges, highest occupied and lowest unoccupied molecular orbitals, dipole moments, and Laplacian plots. The computed ionization potential and electron affinity show that curcumin has a low molecular hardness and thus has a propensity to dissociate its phenolic -OH, and the resulting charge undergoes delocalization throughout the structure, resulting in excitonic features. This feature seems to be also important for its binding capability to human proteins such as human serum albumin and Abeta.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 19127718     DOI: 10.1021/jf0603533

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  30 in total

1.  Studies on curcumin and curcuminoids. XLVI. Photophysical properties of dimethoxycurcumin and bis-dehydroxycurcumin.

Authors:  L Nardo; A Andreoni; M Bondani; M Másson; T Haukvik; H H Tønnesen
Journal:  J Fluoresc       Date:  2011-10-27       Impact factor: 2.217

2.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

Review 3.  Therapeutic potential of curcumin in digestive diseases.

Authors:  Pietro Dulbecco; Vincenzo Savarino
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

4.  Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles.

Authors:  Aysegul Altunbas; Seung J Lee; Sigrid A Rajasekaran; Joel P Schneider; Darrin J Pochan
Journal:  Biomaterials       Date:  2011-05-23       Impact factor: 12.479

5.  β-dicarbonyl enolates: a new class of neuroprotectants.

Authors:  Richard M LoPachin; Terrence Gavin; Brian C Geohagen; Lihai Zhang; Diana Casper; Rukmani Lekhraj; David S Barber
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

6.  Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia.

Authors:  Puneet Rinwa; Baljinder Kaur; Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-06       Impact factor: 3.000

7.  Turmeric and curcumin suppress presenilin 1 protein expression in Jurkat cells.

Authors:  Hitomi Yoshida; Naoko Okumura; Yuri Nishimura; Yasuko Kitagishi; Satoru Matsuda
Journal:  Exp Ther Med       Date:  2011-04-01       Impact factor: 2.447

8.  Fluorescence enhancement of the silver nanoparticales--curcumin-cetyltrimethylammonium bromide-nucleic acids system and its analytical application.

Authors:  Haiping Zhou; Xia Wu; Wei Xu; Jinghe Yang; Qiuxia Yang
Journal:  J Fluoresc       Date:  2010-03-04       Impact factor: 2.217

9.  Structurally distinct toxicity inhibitors bind at common loci on β-amyloid fibril.

Authors:  Ben Keshet; Jeffrey J Gray; Theresa A Good
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

10.  Enolate-Forming Phloretin Pharmacophores: Hepatoprotection in an Experimental Model of Drug-Induced Toxicity.

Authors:  Brian C Geohagen; Amaresh Vydyanathan; Boleslav Kosharskyy; Naum Shaparin; Terrence Gavin; Richard M LoPachin
Journal:  J Pharmacol Exp Ther       Date:  2016-03-30       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.